Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Assembly Biosciences (ASMB – Research Report) and Brainsway (BWAY – Research Report).
Assembly Biosciences (ASMB)
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Assembly Biosciences today and set a price target of $3.50. The company’s shares closed last Wednesday at $2.16.
According to TipRanks.com, Arce is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Assembly Biosciences with a $10.88 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Brainsway (BWAY)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Brainsway today and set a price target of $15.00. The company’s shares closed last Wednesday at $4.90, close to its 52-week low of $4.35.
According to TipRanks.com, Selvaraju ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Brainsway is a Moderate Buy with an average price target of $12.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ASMB:
- 2 ‘Mega Stocks’ with Solid Potential to Outperform the Market
- H.C. Wainwright Thinks Tyra Bioscience’s Stock is Going to Recover
- H.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)
- H.C. Wainwright Sticks to Their Buy Rating for Vertex Energy (VTNR)
- J.P. Morgan Sticks to Their Buy Rating for Nike (NKE)
